ChemicalBook > Product Catalog >API >Urinary System Drugs >Diuretics Drugs >Furosemide

Furosemide

Furosemide Structure
CAS No.
54-31-9
Chemical Name:
Furosemide
Synonyms
FRUSEMIDE;FUROSEMID;fursemide;Furosemide Injection;lasix;salix;4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID;4-chloro-2-((furan-2-ylMethyl)aMino)-5-sulfaMoylbenzoic acid;ERIS;Furix
CBNumber:
CB2445739
Molecular Formula:
C12H11ClN2O5S
Molecular Weight:
330.74
MOL File:
54-31-9.mol
MSDS File:
SDS
Modify Date:
2024/12/18 14:07:02

Furosemide Properties

Melting point 220 °C (dec.) (lit.)
Boiling point 582.1±60.0 °C(Predicted)
Density 1.606
refractive index 1.6580 (estimate)
Flash point 11 °C
storage temp. 2-8°C
solubility Practically insoluble in water, soluble in acetone, sparingly soluble in ethanol (96 per cent), practically insoluble in methylene chloride. It dissolves in dilute solutions of alkali hydroxides.
pka pKa 3.8 (Uncertain)
form powder
color White to Off-White
Water Solubility Soluble in acetone, DMF or methanol. Slightly soluble in water
Merck 14,4309
BCS Class 2 (CLogP), 4 (LogP)
Stability Stable, but light sensitive, air sensitive and hygroscopic. Incompatible with strong oxidizing agents.
InChIKey ZZUFCTLCJUWOSV-UHFFFAOYSA-N
CAS DataBase Reference 54-31-9(CAS DataBase Reference)
IARC 3 (Vol. 50) 1990
EPA Substance Registry System Furosemide (54-31-9)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H302-H360FD
Precautionary statements  P202-P264-P270-P280-P301+P312-P308+P313
Hazard Codes  T,F,Xi
Risk Statements  61-39/23/24/25-23/24/25-11-36/37/38
Safety Statements  7-16-36/37-45-53-36/37/39-22-36-26
RIDADR  UN 1230 3/PG 2
WGK Germany  3
RTECS  CB2625000
HS Code  2935904000
Hazardous Substances Data 54-31-9(Hazardous Substances Data)
Toxicity LD50 orally in female, male rats: 2600, 2820 mg/kg (Goldenthal)

Furosemide price More Price(10)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) F4381 Furosemide 54-31-9 1G ₹5715.6 2022-06-14 Buy
Sigma-Aldrich(India) SAB1306550 ANTI-TM173(C-TERMINAL) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution 54-31-9 400μL ₹47796.6 2022-06-14 Buy
Sigma-Aldrich(India) F4381 Furosemide 54-31-9 5G ₹27019.2 2022-06-14 Buy
Sigma-Aldrich(India) SAB1306152 ANTI-TM173(C-TERMINAL) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution 54-31-9 400μL ₹47796.6 2022-06-14 Buy
Sigma-Aldrich(India) F4381 Furosemide 54-31-9 10G ₹31457.45 2022-06-14 Buy
Product number Packaging Price Buy
F4381 1G ₹5715.6 Buy
SAB1306550 400μL ₹47796.6 Buy
F4381 5G ₹27019.2 Buy
SAB1306152 400μL ₹47796.6 Buy
F4381 10G ₹31457.45 Buy

Furosemide Chemical Properties,Uses,Production

Description

Furosemide (Item No. 26298) is an analytical reference standard categorized as a diuretic. Formulations containing diuretics, including furosemide, have been misused in sports for weight reduction and as masking agents in humans and to prevent exercise-induced pulmonary hemorrhage in racehorses. This product is intended for use in analytical forensic applications. This product is also available as a general research tool .

Chemical Properties

white to light yellow crystal powde

Uses

Furosemide inhibits ion co-transport in the kidney. Furosemide is used as a diuretic.

Definition

A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration and anti-hypertensive agent.

General Description

Odorless white to slightly yellow crystalline powder. A diuretic drug. Almost tasteless.

Air & Water Reactions

Light sensitive. Air sensitive. Slightly soluble in water.

Reactivity Profile

Furosemide may undergo hydrolysis at sufficiently low pH. The pH of aqueous solutions should be maintained in the basic range to prevent hydrolysis. Alcohol has been shown to improve the stability of Furosemide. Incompatible with strong oxidizing agents .

Hazard

Poison; moderately toxic; teratogen; questionable carcinogen; mutagen.

Fire Hazard

Flash point data for Furosemide are not available; however, Furosemide is probably combustible.

Biological Activity

Loop diuretic that inhibits the Na + /2Cl - /K + (NKCC) cotransporter. Also acts as a non-competitive antagonist at GABA A receptors with ~ 100-fold greater selectivity for α 6-containing receptors than α 1-containing receptors.

Mechanism of action

Furosemide is a highly effective and quick-acting diuretic whose action, like all of the examined loop diuretics, is associated with blocking reabsorption of ions in the ascending bend of Henle’s loop. It is used for edema syndrome of various origins, edema of the lungs and brain, chronic renal insufficiency, some forms of hypertonic crises, and poisoning by barbiturates and other compounds excreted mainly with urine.

Clinical Use

Furosemide has a saluretic effect 8- to 10-fold that of the thiazide diuretics; however, it has a shorter duration of action (~6–8 hours). Furosemide causes a marked excretion of sodium, chloride, potassium, calcium, magnesium, and bicarbonate ions, with as much as 25% of the filtered load of sodium excreted in response to initial treatment. It is effective for the treatment of edemas connected with cardiac, hepatic, and renal sites. Because it lowers the blood pressure similar to the thiazide derivatives, one of its uses is in the treatment of hypertension.

Side effects

Clinical toxicity of furosemide and other loop diuretics primarily involves abnormalities of fluid and electrolyte balance. As with the thiazide diuretics, hypokalemia is an important adverse effect that can be prevented or treated with potassium supplements or coadministration of potassium-sparing diuretics. Increased calcium ion excretion can be a problem for postmenopausal osteopenic women, and furosemide generally should not be used in these individuals. Hyperuricemia, glucose intolerance, increased serum lipid levels, ototoxicity, and gastrointestinal side effects might be observed as well. Hypersensitivity reactions also are possible with furosemide (a sulfonamide-based drug), and cross-reactivity with other sulfonamide containing drugs is possible.

Safety Profile

Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Human systemic effects by intravenous route: change in the sensitivity of the ear to sound, tinnitus, unspecified effects on the heart, constriction of the arteries, a decrease in urine volume, interstitial nephritis, metabolic alkalosis, pulse rate decrease, fall in blood pressure. Ingestion can damage the liver. Experimental teratogenic and reproductive effects. Questionable carcinogen with experimental carcinogenic effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of Cl-, NOx, and SOx.

Furosemide Preparation Products And Raw materials

Global( 656)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Jigs Chemical ltd +919099003427 Gujarat, India 239 58 Inquiry
HEMA PHARMACEUTICALS PVT LTD +91-9537936912 +91-9537936912 Gujarat, India 48 58 Inquiry
THE MOLECULEZ +91-7506703683 +91-7506703683 Maharashtra, India 79 58 Inquiry
Hem-Deep Organics Pvt. Ltd. (HOPL) +91-9998689897 +91-9824114578 Gujarat, India 12 58 Inquiry
Ipca Laboratories Ltd +91-2262105000 +91-2262105000 Maharashtra, India 61 58 Inquiry
Prachi Pharmaceuticals Pvt Ltd +919004877711 Mumbai, India 36 58 Inquiry
Macleods Pharmaceuticals Limited +91-2266762800 +91-2266762800 Maharashtra, India 116 58 Inquiry
Vasoya Industries Pvt Ltd +91-9898083583 +91-9898083583 Gujarat, India 42 58 Inquiry
Lakshmi Farmachem +91-9948795885 +91-9550886476 Telangana, India 407 58 Inquiry
Mangalam Drugs and Organics Ltd +91-2222616300 +91-2222616200 Maharashtra, India 37 58 Inquiry

Related articles

  • Side effects of Furosemide
  • Furosemide is the diuretic of choice in acute pulmonary oedema or other states of fluid overload (e.g. cardiac, renal or liver....
  • Feb 24,2022
5-(AMINOSULPHONYL)-4-CHLORO-2-[(2-FURANYLMETHYL)AMINO]BENZOIC ACID 5-[AMINOSULFONYL]-4-CHLORO-2-[(2-FURANYLMETHYL)AMINO]BENZOIC ACID LABOTEST-BB LT00244801 FUROSEMIDE 2-furfurylamino-4-chloro-5-sulfamoylbenzoic acid FUROSEMIDE METHANOL SOLUTION FUROSEMIDE, RELATED COMPOUND B 4-CHLORO-5-SULFAMOYLANTHRANILIC ACID USP STANDARD FUROSEMIDE, EP STANDARD FUROSEMIDE, IMP. A (EP):2-CHLORO-4-FURFURYLAMINO-5-SULPHAMOYLBENZOIC ACID MM(CRM STANDARD) FUROSEMIDE, IMP. B (EP): 2,4-DICHLORO-5-SULPHAMOYLBENZOIC ACID MM(CRM STANDARD) FUROSEMIDE, MM(CRM STANDARD) FUROSEMIDE, WHO(CRM STANDARD) FUROSEMIDE, IMP. C (EP): 2-AMINO-4-CHLORO-5-SULPHAMOYLBENZOIC ACID MM(CRM STANDARD) FUROSEMIDE, IMPURITY A2-CHLORO-4-(FURFURYLAMINO)-5-SULPHAMOYLBENZOIC ACID EP STANDARD FUROSEMIDE, USP STANDARD FUROSEMIDE, BP STANDARD(CRM STANDARD) FUROSEMIDE, RELATED COMPOUND A 2-CHLORO-4-N-FURFURYLAMINO-5-SULFAMOYLBENZOIC ACID USP STANDARD FUROSEMIDE UNLABELED 1.0 MG/ML IN METHANOL Furosemide for peak identification ANTI-TM173(C-TERMINAL) antibody produced in rabbit ERIS TMEM173 Transmembrane protein 173 Furosemide (furosemide) Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-(2-furanylmethyl)amino- FUROSEMIDE,1.0MG/MLINMETHANOL FUROSEMIDE,USP 4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid 4-CHLORO-N-(2-FURYLMETHYL)-5-SULPHAMOYLANTHRANILICACID FUROSEMIDE (FRUSEMIDE) 5-(Aminosulfonyl)-4-chloro-2-[(2-pyranylmethyl)-amino]benzonium acid 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid, 5-(Aminosulfonyl)-4-chloro-2-([2-furanylmethyl]amino)benzoic acid Furosemide solution Furix Furomex Lazax N-(2-furylmethyl)-4-chloro-5-sulfamylanthranilic acid "mita" 4-chloro-n-(2-furylmethyl)-5-sulfanoylanthranilicacid 4-chloro-n-furfuryl-5-sulfamoyl-anthranilicaci 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-benzoicaci 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]-benzoicaci 5-(Aminosulfonyl)-4-chloro-2-[2-(furamyl-methyl)amino]-benzoicacid aluzine aquasin arasemide chlor-n-(2-furylmethyl)-5-sulfamylanthranilsaeure diurolasa endural franyl frusemin furanthril furanthryl furantril furose furosemide"mita" furosemidu furoside